The genetic aetiology of a major fraction of patients with intellectual disability (ID) remains
unknown. De novo mutations (DNMs) in protein-coding genes explain up to 40% of cases, but …

… Correspondence should be addressed to Shweta Joshi; shjoshi@ucsd.edu … Unpublished
results by Joshi et al. suggest that SF2523 is an immunooncological inhibitor that hits tumor …

Neuroblastoma (NB) is the most common pediatric tumor malignancy that originates from the
neural crest and accounts for more than 15% of all the childhood deaths from cancer. The …

Although it is well-established that the macrophage M1 to M2 transition plays a role in tumor
progression, the molecular basis for this process remains incompletely understood. Herein, …

Tumor growth, progression, and response to the hypoxic tumor microenvironment involve
the action of hypoxia-inducible transcription factors, HIF1 and HIF2. HIF is a heterodimeric …

MYC is a major cancer driver but is documented to be a difficult therapeutic target itself. Here,
we report on the biological activity, the structural basis, and therapeutic effects of the family …

Hypoxia-inducible factor 1 (HIF1) is a heterodimeric transcription factor containing an inducibly
expressed HIF1α subunit and a constitutively expressed HIF1β subunit. Under hypoxic …

Hemophilic arthropathy is a debilitating condition that can develop as a consequence of
frequent joint bleeding despite adequate clotting factor replacement. The mechanisms leading …

Neuroblastoma is the most common extracranial pediatric tumor and often presents with
metastatic disease, and patients with high-risk neuroblastoma have survival rates of ~50%. …

Deregulated PI3K/AKT/mTOR, Ras/Raf/MAPK, and c-Myc signaling pathways are of
prognostic significance in hepatocellular carcinoma (HCC). Sorafenib, the only drug clinically …